Trial Profile
Neoadjuvant treatment with intravitreal Avastin for large uveal melanomas
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Jun 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Uveal melanoma
- Focus Therapeutic Use
- 21 Jan 2008 Status changed to recruiting.
- 19 Apr 2007 New trial record.